# Pharmacokinetics of AP214 Acetate in Patients Undergoing Cardiac Surgery

> **NCT00903604** · PHASE2 · COMPLETED · sponsor: **Action Pharma A/S** · enrollment: 42 (actual)

## Conditions studied

- Cardiac Surgery
- Coronary Artery Bypass Grafting
- Valve Surgery
- Aortic Root or Ascending Aortic Aneurysm Repair Surgery

## Interventions

- **DRUG:** AP214
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT00903604
- **Lead sponsor:** Action Pharma A/S
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2009-05
- **Primary completion:** 2010-06
- **Final completion:** 2010-06
- **Target enrollment:** 42 (ACTUAL)
- **Last updated:** 2011-05-17


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00903604

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00903604, "Pharmacokinetics of AP214 Acetate in Patients Undergoing Cardiac Surgery". Retrieved via AI Analytics 2026-05-26 from https://api.ai-analytics.org/clinical/NCT00903604. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*